Efficacy of Dupilumab in Patients with Moderate-to-Severe Asthma and Persistent Airflow Obstruction. Hanania NA, Castro M, Bateman E, Pavord ID, et al. Ann Allergy Asthma Immunol 2022 Nov 1. pii: S1081-1206(22)01899.

Read + Share

Amedeo Smart

Independent Medical Education

Hanania NA, Castro M, Bateman E, Pavord ID, et al. Efficacy of Dupilumab in Patients with Moderate-to-Severe Asthma and Persistent Airflow Obstruction. Ann Allergy Asthma Immunol 2022 Nov 1. pii: S1081-1206(22)01899.
PMID: 36332763